Lefrançois L, Barrett T A, Havran W L, Puddington L
Department of Medicine, University of Connecticut Health Center, Farmington 06030.
Eur J Immunol. 1994 Mar;24(3):635-40. doi: 10.1002/eji.1830240322.
A novel monoclonal antibody, 2E7, was shown by immunoprecipitation to be reactive with the alpha IEL beta 7 integrin and was employed to analyze the expression of this integrin in lymphocyte subsets and during T cell ontogeny. In adult lymph nodes, alpha IEL was expressed at low levels by 40-70% of CD8+ T cells and < 5% of CD4+ T cells. However, virtually all intestinal intraepithelial lymphocytes and approximately 20% of lamina propria CD4+ T cells were 2E7+, indicating a preferential expression of this integrin on mucosal T cells. Examination of alpha IEL integrin expression during thymus ontogeny revealed that approximately 3-5% of fetal or adult thymocytes were 2E7+. Interestingly, early in fetal thymus ontogeny, approximately 40% of 2E7+ cells expressed T cell receptor (TcR)-gamma delta and this subset persisted through birth. A developmental switch occurred such that 2E7+ TcR- CD4-8+ cells detected on fetal day 19 were followed by 2E7+ TcR-alpha beta CD4-8+ cells in the neonatal thymus. The latter population persisted throughout thymus ontogeny into adulthood. Interestingly, a subset of TcR-gamma delta V gamma 3+ day 16 fetal thymocyte dendritic epidermal cell (DEC) precursors were 2E7+, but all mature DEC expressed high levels of alpha IEL integrin, suggesting that the alpha IEL integrin was acquired late in DEC maturation. This possibility was strengthened by immunohistochemical localization of the majority of 2E7+ gamma delta and alpha beta T cells to the medullary regions of the thymus. Overall, the results demonstrate a developmentally ordered expression pattern of the alpha IEL beta 7 integrin that suggests a common function for this integrin during TcR-gamma delta and -alpha beta CD4-8+ T cell thymocyte development or perhaps in effector functions for these subsets.
一种新型单克隆抗体2E7经免疫沉淀显示可与αIELβ7整合素发生反应,并被用于分析该整合素在淋巴细胞亚群以及T细胞个体发育过程中的表达情况。在成年淋巴结中,40 - 70%的CD8 + T细胞低水平表达αIEL,而CD4 + T细胞中表达该整合素的比例小于5%。然而,几乎所有肠上皮内淋巴细胞以及约20%的固有层CD4 + T细胞呈2E7阳性,表明该整合素在黏膜T细胞上优先表达。对胸腺个体发育过程中αIEL整合素表达的检测显示,约3 - 5%的胎儿或成年胸腺细胞呈2E7阳性。有趣的是,在胎儿胸腺个体发育早期,约40%的2E7阳性细胞表达T细胞受体(TcR)-γδ,且该亚群持续存在至出生。随后发生了发育转变,在胎儿第19天检测到的2E7阳性TcR - CD4 - 8 +细胞之后,新生儿胸腺中出现了2E7阳性TcR - αβ CD4 - 8 +细胞。后者群体在整个胸腺个体发育过程中持续存在直至成年。有趣的是,一部分胎儿第16天的TcR - γδ Vγ3 +胸腺细胞树突状表皮细胞(DEC)前体呈2E7阳性,但所有成熟的DEC均高表达αIEL整合素,这表明αIEL整合素是在DEC成熟后期获得的。胸腺中大多数2E7阳性γδ和αβ T细胞定位于髓质区域,这一免疫组化定位结果进一步支持了上述可能性。总体而言,结果表明αIELβ7整合素具有发育有序的表达模式,提示该整合素在TcR - γδ和 - αβ CD4 - 8 + T细胞胸腺细胞发育过程中或许具有共同功能,或者在这些亚群的效应功能中发挥作用。